Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome - PubMed

Review

Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome

Masaharu Akiyama et al. Int J Hematol. 2015 Dec.

Abstract

Maffucci syndrome is a nonhereditary congenital disorder characterized by multiple enchondromas and with soft-tissue hemangiomas. Somatic mutations of the isocitrate dehydrogenase (IDH) gene have been detected in enchondroma and hemangioma tissue from patients with Maffucci syndrome. The rate of malignant transformation in Maffucci syndrome is high, with enchondromas transforming into chondrosarcomas and the development of secondary neoplasms, including pancreatic and hepatic adenocarcinoma, mesenchymal ovarian tumors, and brain tumors such as glioma. However, hematopoietic malignancies arising in Maffucci syndrome are rare. We report a 7-year-old girl with Maffucci syndrome in whom acute myeloid leukemia (AML) with cup-like nuclear invagination developed. Both leukemic cells and hemangioma had the same gene mutations: an insertion frameshift c.863_864insTCTG (p.W288 fs) in the nucleophosmin (NPM1) gene and a missense mutation c.392_395GTCG > CTCT (p.G131_R132 > AL) in the IDH1 gene. However, buccal mucosa cells and peripheral blood mononuclear cells harvested after two cycles of chemotherapy showed wild-type genotypes. These results suggest that the multiple somatic mutations of the IDH1 and NPM1 genes in hemangioblasts are related to the development of cup-like AML associated with Maffucci syndrome. However, further studies are needed to identify additional molecular events in AML but not in hemangioma.

Keywords: Acute myeloid leukemia; Hemangioma; Isocitrate dehydrogenase; Maffucci syndrome; Nucleophosmin.

Similar articles

• Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia.

  Hirabayashi S, Seki M, Hasegawa D, Kato M, Hyakuna N, Shuo T, Kimura S, Yoshida K, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Kiyokawa N, Miyano S, Ogawa S, Takita J, Manabe A. Hirabayashi S, et al. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26647. Epub 2017 May 24. Pediatr Blood Cancer. 2017. PMID: 28544751

• A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report.

  Ashirov N, Mammadinova I, Moldabekov A, Zhetpisbaev B, Teltayev D, Ryskeldiyev N, Akshulakov S. Ashirov N, et al. Medicina (Kaunas). 2023 May 31;59(6):1056. doi: 10.3390/medicina59061056. Medicina (Kaunas). 2023. PMID: 37374260 Free PMC article.

• Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.

  Hao S, Hong CS, Feng J, Yang C, Chittiboina P, Zhang J, Zhuang Z. Hao S, et al. J Neurosurg. 2016 Jun;124(6):1562-7. doi: 10.3171/2015.4.JNS15191. Epub 2015 Oct 16. J Neurosurg. 2016. PMID: 26473790 Free PMC article.

• Maffucci syndrome and neoplasms: a case report and review of the literature.

  Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H. Prokopchuk O, et al. BMC Res Notes. 2016 Feb 27;9:126. doi: 10.1186/s13104-016-1913-x. BMC Res Notes. 2016. PMID: 26920730 Free PMC article. Review.

• IDH mutations in glioma and acute myeloid leukemia.

  Dang L, Jin S, Su SM. Dang L, et al. Trends Mol Med. 2010 Sep;16(9):387-97. doi: 10.1016/j.molmed.2010.07.002. Epub 2010 Aug 5. Trends Mol Med. 2010. PMID: 20692206 Review.

Cited by

• IDH Mutations Are Potentially the Intrinsic Genetic Link among the Multiple Neoplastic Lesions in Ollier Disease and Maffucci Syndrome: A Clinicopathologic Analysis from a Single Institute in Shanghai, China.

  Chen C, Li J, Jiang T, Tang J, Zhang Z, Luo Y, Wang X, Sun K, Jiang Z, Zhou J, Liu Z. Chen C, et al. Diagnostics (Basel). 2022 Nov 11;12(11):2764. doi: 10.3390/diagnostics12112764. Diagnostics (Basel). 2022. PMID: 36428825 Free PMC article.

• Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA.

  Revencu N, Eijkelenboom A, Bracquemart C, Alhopuro P, Armstrong J, Baselga E, Cesario C, Dentici ML, Eyries M, Frisk S, Karstensen HG, Gene-Olaciregui N, Kivirikko S, Lavarino C, Mero IL, Michiels R, Pisaneschi E, Schönewolf-Greulich B, Wieland I, Zenker M, Vikkula M. Revencu N, et al. Orphanet J Rare Dis. 2024 May 22;19(1):213. doi: 10.1186/s13023-024-03196-9. Orphanet J Rare Dis. 2024. PMID: 38778413 Free PMC article.

• Germline Predisposition to Hematolymphoid Neoplasia.

  Weinberg OK, Kuo F, Calvo KR. Weinberg OK, et al. Am J Clin Pathol. 2019 Aug 1;152(3):258-276. doi: 10.1093/ajcp/aqz067. Am J Clin Pathol. 2019. PMID: 31309983 Free PMC article. Review.

• IDH1 as a Cooperating Mutation in AML Arising in the Context of Shwachman-Diamond Syndrome.

  Mourad S, Bilodeau M, Roussy M, Laramée L, Boulianne L, Rouette A, Jouan L, Gendron P, Duval M, Teira P, Hébert J, Bittencourt H, Pastore Y, Landry JR, Cellot S. Mourad S, et al. Front Oncol. 2019 Aug 14;9:772. doi: 10.3389/fonc.2019.00772. eCollection 2019. Front Oncol. 2019. PMID: 31475115 Free PMC article.

• The Utility of PET/CT for the Diagnosis of Periosteal Chondrosarcoma in a Patient With Maffucci's Syndrome.

  Jain A, Cassuto J, Sfakianaki E, Kuker RA, Alizai H, Mohiuddin S. Jain A, et al. Cureus. 2023 Oct 5;15(10):e46552. doi: 10.7759/cureus.46552. eCollection 2023 Oct. Cureus. 2023. PMID: 37822693 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal